Li Zhiwen, Ren Aiguo, Zhang Le, Ye Rongwei, Li Song, Zheng Junchi, Hong Shixin, Wang Taimei, Li Zhu
Institute of Reproductive and Child Health, Peking University Health Science Center, People's Republic of China.
Birth Defects Res A Clin Mol Teratol. 2006 Apr;76(4):237-40. doi: 10.1002/bdra.20248.
In the past, northern China's Shanxi Province has reported the highest incidence of neural tube defects (NTDs) in the world. However, little is known about the epidemiology of NTDs in this area in recent years.
Data were collected from a population-based birth defects surveillance system in 4 counties that captures information on all live births, stillbirths of at least 20 weeks' gestation, and pregnancy terminations at any gestational age resulting from prenatal diagnosis of a birth defect. We also surveyed mothers of NTD case patients to determine their use of folic acid before and during early pregnancy.
During 2003, 160 NTD cases were identified among 11,534 births (NTD birth prevalence = 138.7/10,000 births). The rates of anencephaly, spina bifida and encephalocele were 65.9, 58.1, and 14.7 per 10,000, respectively, and a female predominance was observed among anencephaly cases (male-to-female relative risk [RR], 0.49; 95% confidence interval [CI], 0.30-0.79), but not among spina bifida (RR, 0.90; 95% CI, 0.55-1.45) and encephalocele (RR, 1.03; 95% CI, 0.40-2.69) cases. The percentages of pregnancy termination following prenatal diagnosis of anencephaly, spina bifida, and encephalocele were 50%, 41.8%, and 35.3%, respectively. NTD birth prevalence tended to be higher among mothers aged <20 or > or =30 years (P = .06) and was markedly associated with lower levels of maternal education (P < .001). Among 143 NTD mothers, only 6 (4.2%) used folic acid supplements during the periconceptional period.
The NTD birth prevalence rate in the study area is among the highest worldwide. Folic acid deficiency may be one important risk factor.
过去,中国北方的山西省曾报告神经管缺陷(NTDs)发病率为世界最高。然而,近年来该地区神经管缺陷的流行病学情况鲜为人知。
从4个县基于人群的出生缺陷监测系统收集数据,该系统记录所有活产、妊娠至少20周的死产以及因产前诊断出生缺陷而在任何孕周终止妊娠的情况。我们还对神经管缺陷病例患者的母亲进行了调查,以确定她们在孕早期之前和期间叶酸的使用情况。
2003年期间,在11534例出生中发现160例神经管缺陷病例(神经管缺陷出生患病率 = 138.7/10000例出生)。无脑儿、脊柱裂和脑膨出的发生率分别为每10000例65.9例、58.1例和14.7例,无脑儿病例中观察到女性占优势(男女相对风险[RR],0.49;95%置信区间[CI],0.30 - 0.79),但脊柱裂(RR,0.90;95%CI,0.55 - 1.45)和脑膨出(RR,1.03;95%CI,0.40 - 2.69)病例中未观察到。产前诊断为无脑儿、脊柱裂和脑膨出后终止妊娠的比例分别为50%、41.8%和35.3%。年龄小于20岁或大于或等于30岁的母亲中神经管缺陷出生患病率往往较高(P = 0.06),并且与母亲教育水平较低显著相关(P < 0.001)。在143例神经管缺陷母亲中,只有6例(4.2%)在围孕期使用了叶酸补充剂。
研究地区的神经管缺陷出生患病率在世界范围内处于最高水平。叶酸缺乏可能是一个重要的危险因素。